Improving the Diagnosis of Tonsillitis in Emergency Rooms

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

312 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-02-26

Study Completion Date

2022-10-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A point-of-care laboratory (POC) was set at North Hospital, Marseille, France for the diagnosis in less than two hours of tonsillitis caused by known pathogens, close to the reception of Emergency service. In this instance 30% of patients have no etiological diagnosis after the POC tonsillitis tests . This lab has discovered over 200 new species of bacteria in humans, including vector bacteria and opened the field of large Deoxyribonucleic Acid (DNA ) viruses. Also, the laboratory of emerging viruses discovered many Ribonucleic Acid (RNA) viruses transmitted by arthropods. Based on this collection of new pathogens described in POC laboratory, this study proposes to expand the etiological diagnosis strategy of tonsillitis after POC tests.

The objective of this study is to implement a new diagnosis strategy relying on the hypothesis that a second pharyngeal swab would improve the etiological diagnosis of tonsillitis of at least 5%.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Detection of Group A Streptococcus (GAS) in Oral Cavity

NCT02972437

Tonsillitis

UNKNOWN

Tonsillectomy in Recurrent Tonsillitis

NCT00136877

Tonsillitis

UNKNOWN NA

Peritonsillar Abscess: Aspiration Versus Tonsillectomy a Chaud

NCT03326661

Peritonsillar Abscess

UNKNOWN NA

Microbiology of Severe Acute Tonsillitis, Peritonsillar Cellulitis, and Infectious Mononucleosis

NCT02715037

Acute Tonsillitis Peritonsillar Cellulitis Infectious Mononucleosis

UNKNOWN

Surgical Treatment of Tonsillar Abscess

NCT04543708

Tonsillar Abscess

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tonsillitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with clinical diagnosis of tonsillitis

Group Type EXPERIMENTAL

Nasopharyngeal swab

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nasopharyngeal swab

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient admitted at hospital for tonsillitis requiring, for the emergency physician, a microbiological examination with a "POC tonsillitis kit."
* Patient who has freely signed the informed written consent
* Patient affiliated to a social security scheme

Exclusion Criteria

* Pregnant woman, parturient or nursing
* Adult patient under guardianship
* Patient deprived of liberty under court order
* Patient refusing or unable to sign the informed consent form.

Eligible Sex

ALL

Accepts Healthy Volunteers

No